Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine | ||
| dc.conicet.organizacion | University of Illinois at Chicago | |
| dc.conicet.organizacion | Jesse Brown VA Medical Center | |
| dc.conicet.organizacion | University of Illinois at Chicago | |
| dc.conicet.organizacion | Jesse Brown VA Medical Center | |
| dc.conicet.organizacion | Ohio State University | |
| dc.conicet.organizacion | University of Illinois at Chicago | |
| dc.conicet.organizacion | Cleveland Clinic | |
| dc.conicet.organizacion | Cleveland Clinic | |
| dc.conicet.organizacion | Cleveland Clinic | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental | |
| dc.conicet.organizacion | National Cancer Institute | |
| dc.conicet.organizacion | National Cancer Institute | |
| dc.conicet.organizacion | Avanza Laboratories | |
| dc.conicet.organizacion | National Cancer Institute | |
| dc.conicet.organizacion | Ohio State University | |
| dc.conicet.organizacion | University of Illinois at Chicago | |
| dc.conicet.organizacion | Jesse Brown VA Medical Center | |
| dc.conicet.organizacion | University of Illinois at Chicago | |
| dc.conicet.organizacion | Cleveland Clinic | |
| dc.contributor.author | Lavelle, Donald | |
| dc.contributor.author | Vaitkus, Kestis | |
| dc.contributor.author | Ling, Yonghua | |
| dc.contributor.author | Ruiz, Maria A. | |
| dc.contributor.author | Mahfouz, Reda | |
| dc.contributor.author | Peng Ng, Kwok | |
| dc.contributor.author | Negrotto, Soledad | |
| dc.contributor.author | Smith, Nicola | |
| dc.contributor.author | Terse, Pramod | |
| dc.contributor.author | Engelke, Kory J. | |
| dc.contributor.author | Covey, Joseph | |
| dc.contributor.author | Chan, Kenneth K. | |
| dc.contributor.author | DeSimone, Joseph | |
| dc.contributor.author | Saunthararajah, Yogen | |
| dc.date.issued | 2012-02 | |
| dc.description.abstract | The deoxycytidine analog decitabine (DAC) can deplete DNA methyl-transferase 1 (DNMT1) and thereby modify cellular epigenetics, gene expression, and differentiation. However, a barrier to efficacious and accessible DNMT1-targeted therapy is cytidine deaminase, an enzyme highly expressed in the intestine and liver that rapidly metabolizes DAC into inactive uridine counterparts, severely limiting exposure time and oral bioavailability. In the present study, the effects of tetrahydrouridine (THU), a competitive inhibitor of cytidine deaminase, on the pharmacokinetics and pharmacodynamics of oral DAC were evaluated in mice and nonhuman primates. Oral administration of THU before oral DAC extended DAC absorption time and widened the concentration-time profile, increasing the exposure time for S-phase-specific depletion of DNMT1 without the high peak DAC levels that can cause DNA damage and cytotoxicity. THU also decreased interindividual variability in pharmacokinetics seen with DAC alone. One potential clinical application of DNMT1-targeted therapy is to increase fetal hemoglobin and treat hemoglobinopathy. Oral THU-DAC at a dose that would produce peak DAC concentrations of less than 0.2μM administered 2x/wk for 8 weeks to nonhuman primates was not myelotoxic, hypomethylated DNA in the γ-globin gene promoter, and produced large cumulative increases in fetal hemoglobin. Combining oral THU with oral DAC changes DAC pharmacology in a manner that may facilitate accessible noncytotoxic DNMT1-targeted therapy. | es |
| dc.description.fil | Fil: Lavelle, Donald. University of Illinois at Chicago; Estados Unidos. Jesse Brown VA Medical Center; Estados Unidos | |
| dc.description.fil | Fil: Vaitkus, Kestis. University of Illinois at Chicago; Estados Unidos. Jesse Brown VA Medical Center; Estados Unidos | |
| dc.description.fil | Fil: Ling, Yonghua. Ohio State University; Estados Unidos | |
| dc.description.fil | Fil: Ruiz, Maria A.. University of Illinois at Chicago; Estados Unidos | |
| dc.description.fil | Fil: Mahfouz, Reda. Cleveland Clinic; Estados Unidos | |
| dc.description.fil | Fil: Peng Ng, Kwok. Cleveland Clinic; Estados Unidos | |
| dc.description.fil | Fil: Negrotto, Soledad. Cleveland Clinic; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina | |
| dc.description.fil | Fil: Smith, Nicola. National Cancer Institute; Estados Unidos | |
| dc.description.fil | Fil: Terse, Pramod. National Cancer Institute; Estados Unidos | |
| dc.description.fil | Fil: Engelke, Kory J.. Avanza Laboratories; Estados Unidos | |
| dc.description.fil | Fil: Covey, Joseph. National Cancer Institute; Estados Unidos | |
| dc.description.fil | Fil: Chan, Kenneth K.. Ohio State University; Estados Unidos | |
| dc.description.fil | Fil: DeSimone, Joseph. University of Illinois at Chicago; Estados Unidos. Jesse Brown VA Medical Center; Estados Unidos | |
| dc.description.fil | Fil: Saunthararajah, Yogen. University of Illinois at Chicago; Estados Unidos. Cleveland Clinic; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Lavelle, Donald; Vaitkus, Kestis; Ling, Yonghua; Ruiz, Maria A.; Mahfouz, Reda; et al.; Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine; American Society of Hematology; Blood; 119; 5; 2-2012; 1240-1247 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0006-4971 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/91413 | |
| dc.journal.number | 5 | es |
| dc.journal.pagination | 1240-1247 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Blood | es |
| dc.journal.volume | 119 | es |
| dc.language.iso | eng | es |
| dc.publisher | American Society of Hematology | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1182/blood-2011-08-371690 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://ashpublications.org/blood/article/119/5/1240/29815/Effects-of-tetrahydrouridine-on-pharmacokinetics | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Decitabine | es |
| dc.subject | Tetrahydrouridine | es |
| dc.subject.classification | Otras Medicina Básica | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.91a072f7-aa08-474f-a931-1e452b7b5cec_A.pdf
- Tamaño:
- 423.81 KB
- Formato:
- Adobe Portable Document Format